三种评分系统对儿童脓毒症预后的预测价值:受试者工作特征曲线与决策曲线分析
回顾性观察研究纳入贵州医科大学附属医院PICU 2021年6月至2024年4月226例脓毒症患儿,按2024年国际共识分为脓毒症(无休克)与脓毒性休克,比较存活与死亡组临床特征并计算PSS、pSOFA、PELOD-2评分。结果显示死亡组脓毒性休克比例、机械通气比例及三种评分均高于存活组。ROC曲线显示无休克患儿中PSS和PELOD-2预测PICU死亡AUC高(0.924、0.915),PSS最佳;脓毒性休克患儿中PELOD-2最佳(AUC 0.947);三种评分预测从无休克进展为脓毒性休克的AUC为中等(0.777-0.799)。DCA显示在风险阈值0.3时不同场景下净收益排序不同。
要点
- 儿童脓毒症无休克时,PSS预测PICU死亡AUC 0.924(95%CI 0.831-1.000),PELOD-2 AUC 0.915(95%CI 0.818-1.000),PSS表现最佳。
- 脓毒性休克患儿中,PELOD-2预测PICU死亡AUC 0.947(95%CI 0.900-0.994),优于PSS 0.863和pSOFA 0.818。
- 三种评分预测从无休克进展为脓毒性休克的AUC为PSS 0.799、pSOFA 0.777、PELOD-2 0.793,预测价值中等。
- 死亡组脓毒性休克比例84.2%(32/38)vs 存活组23.4%(44/188),机械通气97.4%(37/38)vs 24.5%(46/188),均P<0.05。
- DCA在风险阈值0.3时:无休克死亡预测净收益PSS 0.212>PELOD-2 0.177>pSOFA 0.074;脓毒性休克死亡预测PELOD-2 0.213>PSS 0.174>pSOFA 0.124;进展为休克预测PSS 0.159>pSOFA 0.131>PELOD-2 0.117。
适用人群与场景
- 2021年6月至2024年4月贵州医科大学附属医院PICU收治的226例脓毒症患儿。
- 按2024年国际共识,根据是否存在心血管功能障碍分为脓毒症(无休克)和脓毒性休克。
诊断标准与关键阈值
- 采用PSS、pSOFA和PELOD-2评分系统,以PICU入科后24小时内生理指标最差值计算。
- 按2024年国际共识,根据是否存在心血管功能障碍区分脓毒症(无休克)与脓毒性休克。
研究设计与关键结果
- 回顾性观察研究,226例脓毒症患儿,PICU住院期间存活188例(83.2%),死亡38例(16.8%)。
- 死亡组与存活组在性别、年龄、BMI、感染部位、PICU住院时间无显著差异;死亡组脓毒性休克比例84.2%(32/38)vs 23.4%(44/188),机械通气比例97.4%(37/38)vs 24.5%(46/188),PSS评分7.0(5.0, 8.3)vs 3.0(2.0, 3.0),pSOFA评分8(5, 12)vs 3(2, 5),PELOD-2评分6(5, 9)vs 2(0, 4),均P<0.05。
- 无休克患儿预测PICU死亡AUC:PSS 0.924(95%CI 0.831-1.000),pSOFA 0.666(95%CI 0.438-0.894),PELOD-2 0.915(95%CI 0.818-1.000)。
- 脓毒性休克患儿预测PICU死亡AUC:PSS 0.863(95%CI 0.777-0.950),pSOFA 0.818(95%CI 0.725-0.911),PELOD-2 0.947(95%CI 0.900-0.994)。
- 预测从无休克进展为脓毒性休克AUC:PSS 0.799(95%CI 0.731-0.866),pSOFA 0.777(95%CI 0.707-0.847),PELOD-2 0.793(95%CI 0.733-0.856)。
- DCA风险阈值0.3时净收益:无休克死亡预测PSS 0.212>PELOD-2 0.177>pSOFA 0.074;脓毒性休克死亡预测PELOD-2 0.213>PSS 0.174>pSOFA 0.124;进展为休克预测PSS 0.159>pSOFA 0.131>PELOD-2 0.117。
证据类型、等级与局限
- 回顾性观察研究,单中心,样本量226例。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,PSS和PELOD-2评分对无休克脓毒症患儿PICU住院期间不良结局预测价值高,PSS表现最佳。
- 作者认为,PSS、pSOFA和PELOD-2评分对脓毒性休克患儿PICU住院期间不良预后预测价值高,PELOD-2表现最佳。
- 作者认为,三种评分对从无休克进展为脓毒性休克的预测价值中等。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the value of the Phoenix Sepsis Score (PSS), pediatric Sequential Organ Failure Assessment (pSOFA) and PEdiatric Logistic Organ Dysfunction-2 (PELOD-2) in assessing disease severity and prognosis in children with sepsis.
METHODS: A retrospective observational study was conducted. A total of 226 pediatric patients with sepsis admitted to pediatric intensive care unit (PICU) of the Affiliated Hospital of Guizhou Medical University from June 2021 to April 2024 were enrolled. The gender, age, body mass index (BMI), site of infection, mechanical ventilation requirement, length of PICU stay, and clinical outcome were extracted, together with the physiological variables required by PSS, pSOFA and PELOD-2 scoring systems. The three critical scores were calculated with the worst values of physiological indicators obtained within 24 hours after PICU admission. According to the 2024 international consensus, children were classified as sepsis (without shock) or septic shock depending on the presence of cardiovascular dysfunction. They were further divided into survivors and non-survivors based on the outcome during PICU hospitalization. Clinical characteristics were compared between the two groups. Receiver operator characteristic curve (ROC curve) was used to assess the ability of the three scoring systems to predict death risk during PICU hospitalization in sepsis without shock and in septic shock, as well as progression from sepsis without shock to septic shock. Decision curve analysis (DCA) was employed to examine the clinical utility of the three scoring systems for predicting death risk during PICU hospitalization in children with sepsis without shock and in those with septic shock, as well as progression from sepsis without shock to septic shock.
RESULTS: A total of 226 pediatric patients with sepsis were ultimately included; 188 (83.2%) survived during PICU hospitalization and 38 (16.8%) died. No significant differences were observed between survivors and non-survivors in gender, age, BMI, site of infection, or length of PICU stay. Non-survivors exhibited higher rates of septic shock and mechanical ventilation, together with higher PSS, pSOFA and PELOD-2 scores, than survivors [septic shock: 84.2% (32/38) vs. 23.4% (44/188), mechanical ventilation: 97.4% (37/38) vs. 24.5% (46/188), PSS score: 7.0 (5.0, 8.3) vs. 3.0 (2.0, 3.0), pSOFA score: 8 (5, 12) vs. 3 (2, 5), PELOD-2 score: 6 (5, 9) vs. 2 (0, 4), all P<0.05]. ROC curve analysis showed that the area under the ROC curve (AUC) of PSS, pSOFA, and PELOD-2 scores for predicting death risk during PICU hospitalization in the pediatric patients with sepsis without shock was 0.924 [95% confidence interval (95%CI) was 0.831-1.000], 0.666 (95%CI was 0.438-0.894), and 0.915 (95%CI was 0.818-1.000), respectively. The AUC of PSS, pSOFA, and PELOD-2 scores for predicting death risk during PICU hospitalization in the pediatric patients with septic shock was 0.863 (95%CI was 0.777-0.950), 0.818 (95%CI was 0.725-0.911), and 0.947 (95%CI was 0.900-0.994), respectively. The AUC of PSS, pSOFA, and PELOD-2 scores for predicting progression from sepsis without shock to septic shock in the pediatric patients was 0.799 (95%CI was 0.731-0.866), 0.777 (95%CI was 0.707-0.847), and 0.793 (95%CI was 0.733-0.856), respectively. DCA curve showed that when the death risk threshold during PICU hospitalization in the pediatric patients with sepsis without shock reached 0.3, the net benefit of the three scoring systems as triggers for emergency intervention ranked PSS score (0.212) >PELOD-2 score (0.177) >pSOFA score (0.074). When the death risk threshold during PICU hospitalization in the pediatric patients with septic shock reached 0.3, the net benefit of the three scoring systems as triggers for emergency intervention ranked PELOD-2 score (0.213) >PSS score (0.174) >pSOFA score (0.124). When the risk threshold of progression from sepsis without shock to septic shock in the pediatric patients reached 0.3, the net benefit of the three scoring systems as triggers for emergency intervention ranked PSS score (0.159) >pSOFA score (0.131) >PELOD-2 score (0.117).
CONCLUSIONS: PSS and PELOD-2 scores demonstrate high value for predicting poor outcomes during PICU hospitalization in children with sepsis without shock, with PSS score performing best. PSS, pSOFA and PELOD-2 scores show high predictive value for poor prognosis during PICU hospitalization in septic shock, among which PELOD-2 score performs best. The predictive value of the three scoring systems for progression from sepsis without shock to septic shock is moderate.
参考来源
- Luo Y, Jiang Z, Yang Z, et al. [Predictive value of three scoring systems for pediatric sepsis prognosis: a receiver operator characteristic curve and decision curve analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41833351. doi:10.3760/cma.j.cn121430-20240904-00432
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。